4 free views remaining today

holoprosencephaly 5

ICD-10 Codes

Related ICD-10:

Description

Holoprosencephaly Description

Holoprosencephaly (HPE) is a congenital induction disorder of the brain occurring at 3-6 weeks' gestation, with failed segmentation of the neural tube [5]. This condition results in abnormal development of the brain, leading to various physical and neurological abnormalities.

Key Features:

  • Failure of the prosencephalon (forebrain) to develop normally
  • Incomplete cleavage of the neural tube
  • Abnormal brain development occurring at 3-6 weeks' gestation

Holoprosencephaly is a complex condition that affects both the forebrain and face, making it a rare and serious birth defect [9].

Additional Characteristics

  • abnormal development of the brain
  • failed segmentation of the neural tube
  • congenital induction disorder of the brain
  • various physical and neurological abnormalities
  • failure of the prosencephalon (forebrain) to develop normally
  • incomplete cleavage of the neural tube
  • abnormal brain development occurring at 3-6 weeks' gestation

Signs and Symptoms

Signs and Symptoms of Holoprosencephaly

Holoprosencephaly (HPE) is a malformation sequence with a very variable degree of severity for both the brain and facial abnormalities. Some common signs and symptoms include:

  • Intellectual disability: Associated with HPE, which can range from mild to severe.
  • Seizures: Often present in children diagnosed with this disorder.
  • Small head (microcephaly): Children may have a smaller-than-average head size.
  • Excessive fluid in the brain (hydrocephalus): Fluid accumulation in the brain can occur, leading to increased pressure and potential complications.
  • Muscle control problems: Tight muscles, unpredictable movements, balance issues, or muscle weakness can be present.

These symptoms can vary in severity and may not be present in all cases of holoprosencephaly. The condition is often associated with other developmental delays and physical abnormalities.

References: [5] Signs & Symptoms. [14] [15]

Diagnostic Tests

Diagnostic Tests for Holoprosencephaly

Holoprosencephaly (HPE) can be diagnosed through various tests, especially in more severe cases. Here are some of the diagnostic tests used to identify HPE:

  • Prenatal Ultrasound: This test is often used to detect HPE before birth. A prenatal ultrasound can help healthcare providers identify compatible craniofacial features and other signs that may indicate HPE.
  • Fetal MRI: A fetal MRI is considered the best way to diagnose HPE while the baby is still in the womb. This imaging technique provides detailed images of the brain, which can help confirm a diagnosis of HPE.
  • Karyotype Analysis: Karyotype analysis involves examining the number and structure of chromosomes. This test can help identify genetic abnormalities that may be associated with HPE.
  • Microarray Testing: Microarray testing is another genetic test used to diagnose HPE. It examines the genetic material in a sample of cells to identify any chromosomal imbalances or mutations.
  • Cranial Ultrasonography: Cranial ultrasonography uses sound waves to create images of the brain. This imaging technique can help detect abnormalities in the brain that may be associated with HPE.
  • MRI and CT Scans: MRI (Magnetic Resonance Imaging) and CT scans are used to create detailed images of the brain. These imaging techniques can help diagnose HPE by identifying compatible craniofacial features and other signs of the condition.

These diagnostic tests can provide valuable information about a potential diagnosis of holoprosencephaly. However, it's essential to consult with a healthcare provider for an accurate diagnosis and treatment plan.

References:

  • [5] Mar 14, 2024 โ€” Prenatal diagnosis options include karyotype analysis, microarray testing, cranial ultrasonography, and MRI.
  • [8] Brain imaging scans. MRI and CT scans (computerized tomography scans) can help diagnose HPE. ยท Genetic tests. Genetic tests are often ordered during an initial ...
  • [9] May 9, 2018 โ€” The diagnosis of holoprosencephaly is usually made by MRI or CT of the brain. Holoprosencephaly can sometimes be detected prenatally through ...

Additional Diagnostic Tests

  • Fetal MRI
  • Prenatal Ultrasound
  • Karyotype Analysis
  • Microarray Testing
  • Cranial Ultrasonography
  • MRI and CT Scans

Treatment

Treatment Options for Holoprosencephaly

Holoprosencephaly (HPE) is a structural malformation of the brain that results from complete or incomplete nonseparation of the prosencephalon (forebrain). While there is no standard course of treatment for HPE, various medical interventions can help manage its symptoms and complications.

Classification and Subtypes

HPE is categorized into 4 subtypes:

  • Alobar holoprosencephaly: The most severe form, characterized by a single ventricle and a midline cleft lip and palate.
  • Semilobar holoprosencephaly: A less severe form, where the hemispheres are partially separated but still connected at the midline.
  • Lobar holoprosencephaly: The mildest form, where the hemispheres are almost completely separated but may still be connected by a thin band of tissue.
  • Middle interhemispheric fusion variant (syntelencephaly): A rare subtype characterized by a complete separation of the hemispheres but with a midline cleft lip and palate.

Treatment Approaches

While there is no specific "cure" for HPE, various treatment approaches can help manage its symptoms and complications. These may include:

  • Surgical interventions: To correct physical abnormalities such as cleft lip and palate, or to relieve pressure on the brain.
  • Medications: To control seizures, manage muscle tone, and address other related conditions.
  • Physical therapy, occupational therapy, and speech-language therapy: To help children with HPE develop skills for day-to-day activities.

Symptomatic Treatment

Treatment for HPE is largely symptomatic and supportive. This means that medical interventions focus on managing specific symptoms or complications rather than addressing the underlying condition itself. For example, if a person with HPE develops seizures, treatment may involve anti-seizure medication [9].

It's essential to note that each individual with HPE requires a personalized treatment plan, taking into account their unique needs and circumstances.

References

  • Classification of HPE subtypes: [5]
  • Treatment approaches for HPE: [15]

Recommended Medications

  • anti-seizure medication

๐Ÿ’Š Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses for Alobar Holoprosencephaly

Alobar holoprosencephaly, the most severe form of holoprosencephaly, has a differential diagnosis that includes:

  • Hydranencephaly: This is the main differential diagnosis for alobar HPE with a single large ventricular cavity and absent midline structures.
  • Other forms of HPE: The differential diagnosis also depends on the type of HPE, and other forms such as lobar HPE may have different differentials.

Key Points

  • Alobar HPE is characterized by a single large ventricular cavity and absent midline structures.
  • Hydranencephaly is the main differential for this form of HPE.
  • The differential diagnosis depends on the type of HPE, making it essential to consider the specific subtype when evaluating patients.

References

[5] - This information is based on search result 5, which states that "The differential diagnosis depends on the type of HPE. In alobar HPE with a single large ventricular cavity and absent midline structures, the main differential is hydranencephaly."

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_5214
owl#annotatedSource
t370561
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0110878
core#notation
DOID:0110878
oboInOwl#hasDbXref
MIM:609637
IAO_0000115
A holoprosencephaly that has_material_basis_in heterozygous mutation in the ZIC2 gene on chromosome 13q32.
rdf-schema#label
holoprosencephaly 5
oboInOwl#hasExactSynonym
HPE5
rdf-schema#subClassOf
t370141
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
relatedICD
http://example.org/icd10/Q04.2
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.